Understanding substance use in biracial adolescents and young adults
Substance Use among Biracial Adolescents and Emerging Adults: The Double Jeopardy Hypothesis
This study looks at the challenges that biracial teens and young adults face with substance use, focusing on specific groups like White-American Indian, White-Asian, White-Black, and White-Hispanic youth, to find better ways to help them stay healthy and avoid substance-related problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10897138 on NIH RePORTER |
What this research studies
This research investigates the unique challenges faced by biracial adolescents and emerging adults regarding substance use. It focuses on four specific biracial subgroups: White-American Indian, White-Asian, White-Black, and White-Hispanic youth, who are at a higher risk for substance use and related issues. The study aims to develop and test a new model, the Double Jeopardy Hypothesis, to better understand the factors influencing substance use in these populations. By refining prevention and intervention strategies, the research seeks to improve public health practices for biracial youth.
Who could benefit from this research
Good fit: Ideal candidates for this research are biracial adolescents and emerging adults, particularly those from the identified subgroups at higher risk for substance use.
Not a fit: Patients who are not biracial or do not fall into the specified subgroups may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention and intervention programs tailored specifically for biracial adolescents and young adults.
How similar studies have performed: While there has been limited research specifically targeting biracial youth, similar studies on substance use prevention in diverse populations have shown promising results.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Goings, Trenette Clark — Univ of North Carolina Chapel Hill
- Study coordinator: Goings, Trenette Clark
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.